Marshall Financial Group LLC raised its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 3.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,969 shares of the semiconductor company’s stock after purchasing an additional 74 shares during the quarter. Marshall Financial Group LLC’s holdings in Synopsys were worth $956,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors also recently modified their holdings of the company. Davidson Capital Management Inc. grew its stake in shares of Synopsys by 33,828.6% in the 3rd quarter. Davidson Capital Management Inc. now owns 4,750 shares of the semiconductor company’s stock worth $2,405,000 after acquiring an additional 4,736 shares in the last quarter. Peloton Wealth Strategists grew its position in Synopsys by 221.2% in the 3rd quarter. Peloton Wealth Strategists now owns 2,881 shares of the semiconductor company’s stock worth $1,459,000 after purchasing an additional 1,984 shares in the last quarter. Swiss National Bank increased its stake in Synopsys by 0.7% in the 3rd quarter. Swiss National Bank now owns 454,800 shares of the semiconductor company’s stock valued at $230,306,000 after buying an additional 3,200 shares during the last quarter. Parnassus Investments LLC purchased a new position in shares of Synopsys in the 3rd quarter worth approximately $633,469,000. Finally, Harvest Portfolios Group Inc. grew its holdings in shares of Synopsys by 3.7% in the third quarter. Harvest Portfolios Group Inc. now owns 42,121 shares of the semiconductor company’s stock valued at $21,330,000 after acquiring an additional 1,496 shares in the last quarter. Institutional investors own 85.47% of the company’s stock.
Insider Activity
In other news, CRO Richard S. Mahoney sold 20,838 shares of the stock in a transaction dated Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total value of $10,544,236.38. Following the sale, the executive now directly owns 1,460 shares of the company’s stock, valued at approximately $738,774.60. This represents a 93.45 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.66% of the stock is owned by company insiders.
Synopsys Price Performance
Analysts Set New Price Targets
A number of analysts recently commented on SNPS shares. Redburn Atlantic started coverage on Synopsys in a report on Monday, January 13th. They set a “buy” rating and a $600.00 price target on the stock. Mizuho began coverage on shares of Synopsys in a report on Tuesday, October 22nd. They issued an “outperform” rating and a $650.00 price target on the stock. Berenberg Bank began coverage on shares of Synopsys in a report on Tuesday, October 15th. They set a “buy” rating and a $660.00 price objective for the company. Loop Capital initiated coverage on shares of Synopsys in a research note on Monday, November 11th. They issued a “buy” rating and a $675.00 target price on the stock. Finally, Needham & Company LLC reissued a “buy” rating and set a $640.00 target price on shares of Synopsys in a research report on Thursday, December 5th. One investment analyst has rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $641.82.
Get Our Latest Stock Analysis on Synopsys
Synopsys Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- P/E Ratio Calculation: How to Assess Stocks
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- 3 Tickers Leading a Meme Stock Revival
- Bloom Energy: Powering the Future With Decentralized Energy
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.